Two members of the Federal Communications Commission announced they’ll depart this week, leaving the agency with three vacancies while it reviews a major media merger and investigates a wireless ...

Okta stock beat on sales and earnings last night. Guidance was good as well, with Okta forecasting better-than-expected earnings in Q2 and for all of fiscal 2026, too. However, the growth rate is ...

Agency management is concerned that the mass departures could negatively impact work to improve runway safety and medical clearance processing for pilots and controllers. What is the point of ...

Citing a May 7 internal presentation to senior FAA management, the Journal reported that more than 1,200 recent departures—including senior leaders who oversee air traffic, airlines, and ...

In a series of departures announced in a matter of weeks, the agency’s entire top rung is set to turn over as Brian Quintenz, President Trump’s nominee for CFTC chair, prepares to take the reins.

Pennsylvania Sen. John Fetterman’s chief of staff is leaving her post, two people familiar with the matter confirmed to POLITICO on Tuesday. The move is yet another key departure for a ...

Tesla (TSLA) stock is on the rise after two big pieces of news came overnight: a reported start date for robotaxi testing and CEO Elon Musk's official government departure. Per Bloomberg ...

Tesla stock outperformed its "Magnificent Seven" peers and the broader Nasdaq Composite index during the month of May. S&P 500 +---% | Stock Advisor +---% Join The Motley ...

Broadcom (NASDAQ:AVGO) stock is up nearly 45% in the last six months, significantly outperforming the broader Nasdaq index, down 1%. This strong performance is largely due to the company’s ...

UPDATE: FAA cancels alert about late flight departures from Orlando International Airport Earlier in the evening the agency had issued a notice about departure delays to Orlando from some regions ...

Pfizer (NYSE:PFE) stock is down around 25% from its 52-week high of over $31 to $23 now. Pipeline setbacks, including an experimental treatment for Duchenne muscular dystrophy (DMD) failing in a ...

Palantir's stock has jumped more than tenfold since its IPO. Despite the tremendous growth, the company would need significantly more expansion to make a stock split likely. 10 stocks we like ...